Avinger Inc (AVGR) Stock Price, Quote & News

Company Profile

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 650 241 7900

Website: avinger.com

Address:

400 Chesapeake Drive, Redwood City, United States

MildredCook695 Jun. 6 at 3:08 PM

$AVGR has faded after spikes while ZBAO is climbing with steady buying pressure.

0 · Reply

hossie Jun. 5 at 3:05 PM

$AVGR $ASM Look asm going! 🥳🤑 We gonna hit the 4 this week be quick!

0 · Reply

EricTheMidgetLynch May. 15 at 8:48 PM

$KTTA 10k and 13G both not good 💸 Financials (Q1 2025) • Cash: $5.3M (down from $6.9M in Q4) • Net loss: $3.56M for Q1 (vs. $3.86M in Q1 2024) • Revenue: None (still pre-commercial) • R&D expense: $1.73M • G&A expense: $1.95M • ATM sales: Raised $1.65M in Q1 through equity sales • Ongoing burn rate: ~$1.5M/month ⚠️ Going Concern • Company does not have enough capital to fund 12 months of operations without additional fundraising. 🧾 Recent Offering • May 2025: Raised $6.3M gross by selling 3.57M shares with Series C + D warrants (both $1.40 strike). • 914K shares from Series D warrants were exercised immediately • Remaining warrants are still active = dilution risk Who Is Armistice Capital? 13G • A New York–based hedge fund founded by Steven Boyd • Known for investing in biotech, healthcare, and SPACs • Frequently involved in PIPEs (Private Investment in Public Equity), toxic convertible debt, and warrant-heavy deals Examples of Armistice Deals • $SBFM • $AVGR • $AYRO • $BNGO

0 · Reply

LongBallBarn May. 14 at 5:54 PM

$AVGR

0 · Reply

pilobious May. 9 at 12:45 AM

$AVGR NASDAQ delisted.

1 · Reply

BairdOakmont May. 7 at 7:24 PM

$AVGR Still listed??

0 · Reply

Homeofthebrave Apr. 22 at 12:46 PM

$AVGR As of February 10, 2025, Jeffrey M. Soinski is no longer the CEO of Avinger, Inc. Other members of the Avinger management team include: • Himanshu Patel: Chief Technology Officer • Phil Preuss: Chief Commercial Officer • Jaafer Golzar: Chief Medical Officer • Corey Gibbs: Vice President of Sales • Jay Sundaram: Vice President of Quality Management Representative • Thomas Lawson: Vice President of Clinical & Regulatory Affairs • Elmar Horn: Vice President of International • James G. Cullen, Chairman • James B. McElwee, Director • Tamara Elias, Director Lets go get em (in the courts)!

3 · Reply

ajay26067 Apr. 18 at 1:14 PM

$AVGR fuck this company. Thank you for taking my money 🖕🏾🖕🏾

0 · Reply

Frenchsteele Apr. 16 at 12:11 PM

$AVGR it’s strange how my shares on webull are still on FPSL and I’m still getting paid for these being loaned out.

1 · Reply

ajay26067 Apr. 14 at 1:23 PM

$AVGR are we ever getting our money

2 · Reply

Avinger, Inc. Executes Assignment for the Benefit of Creditors; Announces Receipt of Nasdaq Delisting Notice

Nov 7, 2024, 9:43 PM EST - 7 months ago

Avinger, Inc. (AVGR) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:05 PM EST - 7 months ago

Avinger Reports Third Quarter 2024 Results

Oct 29, 2024, 8:00 AM EDT - 8 months ago

Avinger to Announce Third Quarter 2024 Results on November 7, 2024

Oct 24, 2024, 8:00 AM EDT - 8 months ago

Avinger Releases Updated Data From IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention

Sep 18, 2024, 8:00 AM EDT - 9 months ago

Avinger Announces Issuance of New U.S. Patent and Receives Notices of Allowance for Five Additional U.S. Patents

Aug 20, 2024, 8:30 AM EDT - 10 months ago

Avinger Initiates Full Commercial Launch of Pantheris LV Image-Guided Atherectomy Device

Aug 9, 2024, 12:42 PM EDT - 11 months ago

Avinger, Inc. (AVGR) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:01 PM EDT - 11 months ago

Avinger Reports Second Quarter 2024 Results

Aug 5, 2024, 8:00 AM EDT - 11 months ago

Avinger Appoints Thomas P. Davis, MD, FACC as Chief Medical Officer

Jul 29, 2024, 8:45 AM EDT - 11 months ago

Avinger to Announce Second Quarter 2024 Results on August 8, 2024

Jun 17, 2024, 4:05 PM EDT - 1 year ago

Avinger Announces Closing of up to $24 Million Public Offering

Jun 14, 2024, 8:00 AM EDT - 1 year ago

Avinger Announces Pricing of up to $24 Million Public Offering

Jun 5, 2024, 7:30 AM EDT - 1 year ago

Avinger Increases Focus on Coronary Development, Reduces Operating Costs of Peripheral Business

May 16, 2024, 4:05 PM EDT - 1 year ago

Avinger Announces Conversion of $11 Million of CRG Debt into Preferred Equity

May 15, 2024, 6:15 PM EDT - 1 year ago

Avinger, Inc. (AVGR) Q1 2024 Earnings Call Transcript

May 15, 2024, 4:01 PM EDT - 1 year ago

Avinger Reports First Quarter 2024 Results

May 7, 2024, 8:15 AM EDT - 1 year ago

Avinger to Announce First Quarter 2024 Results on May 15, 2024

Mar 20, 2024, 5:56 PM EDT - 1 year ago

Avinger, Inc. (AVGR) Q4 2023 Earnings Call Transcript

Mar 20, 2024, 4:05 PM EDT - 1 year ago

Avinger Reports Fourth Quarter and Full Year 2023 Results

Mar 12, 2024, 9:00 AM EDT - 1 year ago

Avinger to Announce Full Year 2023 Results on March 20, 2024

Mar 7, 2024, 2:04 AM EST - 1 year ago

Zylox-Tonbridge and Avinger Forge Strategic Partnership to Expand Disruptive OCT Solutions for Peripheral Vascular Interventions

Mar 6, 2024, 7:30 PM EST - 1 year ago

Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge

Oct 26, 2023, 6:23 PM EDT - 1 year ago

Avinger, Inc. (AVGR) Q3 2023 Earnings Call Transcript

Oct 26, 2023, 4:01 PM EDT - 1 year ago

Avinger Reports Third Quarter 2023 Results

Oct 19, 2023, 8:00 AM EDT - 1 year ago

Avinger to Announce Third Quarter 2023 Results on October 26

Sep 27, 2023, 8:00 AM EDT - 1 year ago

Avinger Raises $5.3 Million via At-The-Market Facility

Sep 18, 2023, 11:30 AM EDT - 1 year ago

Avinger stock rockets off a record low after launch of vascular disease treatment system

Sep 18, 2023, 8:00 AM EDT - 1 year ago

Avinger Initiates Full Commercial Launch of Tigereye ST Image-Guided CTO Crossing Device

Aug 24, 2023, 8:00 AM EDT - 1 year ago

Avinger Announces Presentations by Key Opinion Leaders at AMP (The Amputation Prevention Symposium) 2023

Aug 4, 2023, 9:00 AM EDT - 2 years ago

Avinger Announces Conversion of 12% of CRG Term Debt into Equity

Jul 27, 2023, 9:54 PM EDT - 2 years ago

Avinger, Inc. (AVGR) Q2 2023 Earnings Call Transcript

Jul 27, 2023, 4:01 PM EDT - 2 years ago

Avinger Reports Second Quarter 2023 Results

Jul 20, 2023, 8:00 AM EDT - 2 years ago

Avinger to Announce Second Quarter 2023 Results on July 27

Jun 20, 2023, 8:00 AM EDT - 2 years ago

Avinger Announces Presentations by Key Opinion Leaders at LINC 2023

Jun 9, 2023, 8:00 AM EDT - 2 years ago

Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference

Jun 7, 2023, 8:00 AM EDT - 2 years ago

Avinger Receives 510(k) Clearance for Pantheris LV Image-Guided Atherectomy System

Jun 5, 2023, 8:00 AM EDT - 2 years ago

Avinger Announces Successful First Cases with Tigereye ST Image-Guided Chronic Total Occlusion (CTO) Crossing Device

May 10, 2023, 8:38 PM EDT - 2 years ago

Avinger, Inc. (AVGR) Q1 2023 Earnings Call Transcript

May 10, 2023, 4:01 PM EDT - 2 years ago

Avinger Reports First Quarter 2023 Results

May 2, 2023, 8:00 AM EDT - 2 years ago

Avinger to Announce First Quarter 2023 Results on May 10

Apr 28, 2023, 8:00 AM EDT - 2 years ago

Leading Data on the Treatment of In-Stent Restenosis with Pantheris Presented at Charing Cross International Symposium

Apr 26, 2023, 8:00 AM EDT - 2 years ago

Avinger Receives 510(k) Clearance for Tigereye ST Image-Guided CTO Crossing System

Mar 15, 2023, 9:15 PM EDT - 2 years ago

Avinger, Inc (AVGR) Q4 2022 Earnings Call Transcript

Mar 15, 2023, 4:01 PM EDT - 2 years ago

Avinger Reports Fourth Quarter 2022 Results

Mar 2, 2023, 8:00 AM EST - 2 years ago

Avinger to Announce Fourth Quarter 2022 Results on March 15

Jan 11, 2023, 8:15 AM EST - 2 years ago

Avinger Announces 510(k) Filing of Pantheris LV

Nov 13, 2022, 12:11 PM EST - 2 years ago

Avinger, Inc (AVGR) Q3 2022 Earnings Call Transcript

Nov 9, 2022, 4:01 PM EST - 2 years ago

Avinger Reports Third Quarter 2022 Results

Nov 4, 2022, 8:00 AM EDT - 2 years ago

Avinger Announces Issuance of Seven New Patents Expanding Coverage for Its Proprietary Image-Guided Atherectomy Devices

MildredCook695 Jun. 6 at 3:08 PM

$AVGR has faded after spikes while ZBAO is climbing with steady buying pressure.

0 · Reply

hossie Jun. 5 at 3:05 PM

$AVGR $ASM Look asm going! 🥳🤑 We gonna hit the 4 this week be quick!

0 · Reply

EricTheMidgetLynch May. 15 at 8:48 PM

0 · Reply

LongBallBarn May. 14 at 5:54 PM

$AVGR

0 · Reply

pilobious May. 9 at 12:45 AM

$AVGR NASDAQ delisted.

1 · Reply

BairdOakmont May. 7 at 7:24 PM

$AVGR Still listed??

0 · Reply

Homeofthebrave Apr. 22 at 12:46 PM

3 · Reply

ajay26067 Apr. 18 at 1:14 PM

$AVGR fuck this company. Thank you for taking my money 🖕🏾🖕🏾

0 · Reply

Frenchsteele Apr. 16 at 12:11 PM

$AVGR it’s strange how my shares on webull are still on FPSL and I’m still getting paid for these being loaned out.

1 · Reply

ajay26067 Apr. 14 at 1:23 PM

$AVGR are we ever getting our money

2 · Reply

CATATOM Apr. 10 at 2:17 PM

$BTOG $FMTO $DOMH $PLTR $TNXP $TSLA $NVDA $AAPL $GME $AMC $DJT $BTC $ETH $DOGE $SHIB $SPY $XRP $FFIE $GOOG $SOL $TRUMP $ASTS $BHAT $QQQ $NKLA $CYN $MGOL $UPST $LTRY $ATOM $XLO $NAKA $TCBP $TIVC $PEV $EDSA $GNPX $PLRX $AZTR $PRPH $APP $AVGR

0 · Reply

The_Gambl3r Apr. 3 at 4:33 PM

$AVGR 👀🫡

2 · Reply

Geneo12345 Mar. 27 at 8:47 PM

$ABIO $AVGR $OCGN $PULM $SINT I can’t believe this post has resurfaced. 🤣 This was huge in 2021.

2 · Reply

CHTPWinner Mar. 20 at 9:51 PM

$AVGR $48750 good!

0 · Reply

LongBallBarn Mar. 19 at 7:33 PM

$AVGR

0 · Reply

CHTPWinner Mar. 18 at 9:10 PM

$AVGR auction here https://svdisposition.hibid.com/catalog/619596/avinger?s=BID_AMOUNT_HIGH_TO_LOW

2 · Reply

BairdOakmont Mar. 11 at 2:41 PM

$AVGR So, this stock is not delisted…it is just suspended?? I assume the Strategic Shift election they filed for is occurring and a new company emerges. But, since the old leadership team all resigned, I assume there will be new leadership/ownership??

1 · Reply

Stocktracker32 Mar. 10 at 1:40 PM

$AVGR The truth is that any common shareholders shares have been worthless for several years now. There was a little “advertised” clause invoked by the BOD that stated that any proceeds in a sale or liquidation of the company of less than $70M go exclusively to debt holders and preferred shareholders (later issues of preferred). I got out then at a painful loss, but nothing like what you guys who still own this. Sorry for your loss.

1 · Reply

Jerrymandering Mar. 6 at 7:10 PM

$AVGR finally the end of this disaster. Jeff CEO, CFO and fmr VP Sales Cory Al Bundy wannabe player sunk this dumpster fire. 😂🤣☠️🖕

0 · Reply

Homeofthebrave Mar. 6 at 2:32 PM

$AVGR "under California law and my role as assignee is centered around acting in a fiduciary capacity to liquidate assets in a value maximizing manner for the benefit of creditors and shareholders of Avinger." Question is-which creditors and shareholders-the ones who sold to us unknowing buyers used as schleps, or us schleps who were taken in, used by the fraudsters?

2 · Reply

3PintBrain Mar. 5 at 11:06 PM

$AVGR Well the value of my remaining shares of this were removed today. anyone else?

3 · Reply

Janestockaddiction Mar. 3 at 8:17 PM

$AVGR Icky as $LICN

0 · Reply

Market Cap	1.57M
Revenue (ttm)	7.65M
Net Income (ttm)	-18.32M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-239.48%
Debt to Equity Ratio	1.07

Volume	2,592,000
Avg Vol	3,817,300
Day's Range	N/A - N/A
Shares Out	3.31M
Stochastic %K	24%
Beta	1.09
Analysts	Strong Sell
Price Target	$5.00